Gilead Sciences Inc.
S&P 500GILD/Healthcare · Drug Manufacturers - General/NASDAQ
Dividend Yield
2.58%
$3.22 · Annual Dividend
Dividend Safety Rating
GILD's dividend appears very safe. Strengths include a 43.4% earnings payout ratio & 39.4% fcf payout ratio. Areas of concern: Volatile profit margin stability.
Based on 15 of 15 metrics
Strengths
- Earnings Payout Ratio: 43.4%Low earnings payout ratio leaves room to grow the dividend.
- FCF Payout Ratio: 39.4%Free cash flow comfortably covers the dividend.
- Interest Coverage: 10.6xEarnings cover interest payments many times over.
Risks
- Profit Margin Stability: VolatileProfit margins have been volatile.
Payout & Coverage
Very SafeBalance Sheet
SafeProfitability
SafeDividend Track Record
Very SafeAbout Gilead Sciences Inc.
Gilead Sciences Inc. is a biopharmaceutical company that discovers, develops, and commercializes medicines addressing unmet medical needs in infectious diseases, oncology, and other therapeutic areas across the United States, Europe, and international markets. Its portfolio centers on HIV treatments, including leading products like Biktarvy, Genvoya, Descovy, Odefsey, Sunlenca, and Yeztugo, the world's first twice-yearly HIV prevention therapy. The company also offers therapies for viral hepatitis such as Epclusa, Harvoni, Vemlidy, and Viread, alongside Veklury for COVID-19. In oncology and cell therapy, Gilead provides Yescarta, Tecartus, and Trodelvy for various cancers, as well as Livdelzi for primary biliary cholangitis. These products target life-threatening conditions in virology, liver diseases, hematology, inflammation, and respiratory areas, serving patients through innovative antiviral regimens, CAR-T cell therapies, and antibody-drug conjugates. Founded in 1987 and headquartered in Foster City, California, Gilead Sciences Inc. plays a pivotal role in advancing treatments for chronic and infectious diseases globally.
Dividend Overview
Dividend Yield
2.58%
Annual Dividend
$3.22
Frequency
Quarterly
Payout Ratio
43.40%
FCF Payout Ratio
39.42%
52-Week Range
$104.46 - $157.29
Dividend History (2016–2025)
GILD annual dividend per share and yield history
Earnings & Profitability
GILD earnings per share and net profit margin
Key Dates
Last Ex-Dividend Date
June 15, 2026
Next Payment Date
June 29, 2026
Dividend Growth
3-Year Dividend CAGR
2.67%
5-Year Dividend CAGR
3.04%
10-Year Dividend CAGR
9.37%
3-Year Total Growth
8.22%
5-Year Total Growth
16.18%
10-Year Total Growth
144.96%
Income Calculator
Similar Dividend Stocks
Frequently Asked Questions
What is GILD's current dividend yield?
When is GILD's next dividend payment date?
How much does GILD pay in dividends per year?
Has GILD been increasing its dividend?
Is GILD's dividend safe?
How is GILD's Dividend Safety Rating calculated?
Want to understand how we rate dividend safety? Read our full methodology
Track GILD Dividends with OnlyDividends
What will GILD actually pay you after taxes? Track every payout, get notified on payment dates, and stop guessing.
This page is not investment advice. The content is for informational purposes only and should not be construed as a recommendation to buy, sell, or hold any security. Always do your own research and consult a qualified financial advisor before making investment decisions.
Financial data, including dividend history, earnings, balance sheet metrics, and the Dividend Safety Rating, is provided for informational purposes only. Data may be delayed or differ from official filings. Past performance does not guarantee future results. Always verify with official sources before making investment decisions.
Market data provided by Twelve Data.